July 22, 2019 SBP Provides an Update on Ongoing Front-line Pancreatic Cancer Clinical Trial July 22, 2019 SBP Provides an Update on Ongoing Front-line Pancreatic Cancer Clinical Trial Preliminary Efficacy Signals Seen with SBP-101 Administered in Combination with Gemcitabine and Nab-paclitaxel DSMB Approves Enrollment of 3rd and Final Cohort View/download press release »